Research progress in population pharmacokinetics of rituximab / 中国临床药理学与治疗学
Chinese Journal of Clinical Pharmacology and Therapeutics
;
(12): 468-474, 2023.
Article
in Chinese
| WPRIM
| ID: wpr-1014654
ABSTRACT
Rituximab, a chimeric human-mouse monoclonal antibody, has been used as a first-line treatment for CD20
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Clinical Pharmacology and Therapeutics
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS